Skip to main content
. 2022 Mar 14;45(5):1247–1251. doi: 10.2337/dc21-2434

Figure 1.

Figure 1

MoCA score in the empagliflozin, metformin, and insulin groups evaluated at baseline and follow-up. Data are means ± SD. **P < 0.01, ***P < 0.001.